Series C Growth InStride Health recently closed a $30M Series C led by new investors Echo Health Ventures and FMZ Ventures, with continued support from Mass General Brigham Ventures and others, signaling strong growth momentum and potential for expansion into new markets and payer partnerships.

Payer & Insurer Fit As an insurance-based specialty provider for pediatric anxiety and OCD, there is a clear opportunity to partner with health plans, employer-sponsored multi-state programs, and integrated delivery networks seeking specialized, evidence-based cognitive behavioral therapy and exposure therapy for youth.

Awarded Credibility Recognition as Mental Health Innovation Award winner at the 2026 MedTech Breakthrough Awards enhances credibility with potential customers, payers, and referral networks, supporting outreach and co-marketing efforts.

Scale & Geography Funding and recent press indicate expansion into new markets; targeted BD efforts can focus on regions with high pediatric mental health demand, leveraging existing care team model (therapist, exposure coach, psychiatrist) to establish scalable clinic or telehealth partnerships.

Tech & Analytics Utilize the tech stack including AWS Lambda and Tableau to enable data-driven outcomes demonstrations, patient engagement analytics, and payer reporting capabilities to strengthen value propositions for insurers and health systems.